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The crystal structure of pantoprazole sodium sesquihydrate has been solved and refined using syn-
chrotron X-ray powder diffraction data and optimized using density functional techniques.
Pantoprazole sodium sesquihydrate crystallizes in space group Pbca (#61) with a = 33.4862(6),
b = 17.29311(10), c = 13.55953(10) Å, V = 7852.06(14) Å3, and Z = 16. The crystal structure is char-
acterized by layers parallel to the bc-plane. One layer contains the Na coordination spheres. The two
independent sodium ions are trigonal bipyramidal and octahedral. The NaO3N2 and NaO4N2 coordi-
nation spheres share an edge to form pairs. The sodium bond valence sums are 1.17 and 1.15. The
difluoromethyl groups are probably disordered. Two water molecules act as hydrogen bond donors
to pyridine nitrogen atoms and sulfoxide oxygen atoms. The third water molecule participates in bifur-
cated hydrogen bonds, but one of its hydrogen atoms does not participate in hydrogen bonds. The
powder pattern is included in the Powder Diffraction File™ as entry 00-065-1424. © 2020
International Centre for Diffraction Data. [doi:10.1017/S0885715620000019]
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I. INTRODUCTION
Pantoprazole sodium sesquihydrate (brand name Protonix)
is a drug classified as a proton pump inhibitor, which blocks
the final step of acid production in the stomach. The reduction
in acids allows for the prevention of gastroesophageal reflux
disease and related symptoms. Additionally, it is used for the
healing of erosive esophagitis, caused by acid damage to
the esophagus. Pantoprazole is used as a short-term treatment
for symptoms such as heartburn, stomach ulcers, and acid
damage. The IUPAC name (CAS Registry number 164579-
32-2) is 6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)
methylsulfinyl]-1H-benzimidazole sodium sesquihydrate. A
two-dimensional molecular diagram for the pantoprazole
anion is shown in Figure 1.
A low-precision powder pattern of pantoprazole sodium is
contained in PDF entry 00-058-1368 (Badwan et al., 2002),
and a low-precision pattern of pantoprazole sodium sesquihy-
drate is presented in PDF entry 00-058-1451 (Reddy et al.,
2005). Several polymorphs of pantoprazole sodium are
claimed in U.S. Patent 7,507,829 B2 (Finkelstein et al.,
2009). Novel crystalline ketone solvates of pantoprazole
sodium are disclosed in U.S. Patent Application 2005/
024578 (Allegrini et al., 2005).
This work was carried out as a part of a project (Kaduk
et al., 2014) to determine the crystal structures of large-
volume commercial pharmaceuticals and include high-quality
powder diffraction data for these pharmaceuticals in the
Powder Diffraction File (Gates-Rector and Blanton, 2019).
II. EXPERIMENTAL
Pantoprazole sodium sesquihydrate was a commercial
reagent, purchased from United States Pharmacopeial
Convention (USP) (Lot # H0L207), and was used as-received.
The white powder was packed into a 1.5 mm diameter
Kapton capillary and rotated during the measurement at ∼50
Hz. The powder pattern was measured at 295 K at beam line
11-BM (Lee et al., 2008; Wang et al., 2008) of the
Advanced Photon Source at Argonne National Laboratory
using a wavelength of 0.413685 Å from 0.5 to 50° 2θ with a
step size of 0.001° and a counting time of 0.1 s per step.
The pattern was indexed on a primitive orthorhombic unit
cell with a = 33.474, b = 17.290, c = 13.544 Å, V = 7844.5 Å3,
and Z = 16 using Jade 9.8 (MDI, 2018). Jade, EXPO2014
(Altomare et al., 2013), FOX (Favre-Nicolin and Černý,
2002), and JANA2006 (Petricek et al., 2014) all indicated
space group Pbca consistent with the commercial material
being a racemate. A reduced cell search in the Cambridge
Structural Database (Groom et al., 2016) yielded 22 hits,
but no structures for pantoprazole derivatives. A pantoprazole
anion was built using Spartan’18 (Wavefunction, 2018)
and converted into .mol2 and .mop files using OpenBabel
(O’Boyle et al., 2011). After many failures using multiple
programs, the structure was finally solved using Monte
Carlo-simulated annealing techniques as implemented in
EXPO. Two pantoprazole anions, two Na, and three O
a)Author to whom correspondence should be addressed. Electronic mail:
kaduk@polycrystallography.com
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(water molecules) were used as fragments. The 10 runs took
86.5 h. One of the Na and two of the O atom positions were
unreasonable (too close to pantoprazole) and removed from
the model. The Na and two O were located using differentce
Fourier maps. A void was indicated near the difluoromethyl
groups, and a water molecule was inserted there. The TGA
analysis indicated that the water content was 1.5 instead of
2.0, so this water molecule was removed. Initial hydrogen
positions on the water molecules were deduced by an analysis
of potential hydrogen bonding patterns.Figure 1. Molecular structure of the pantoprazole anion.
Figure 2. Rietveld plot for the refinement of pantoprazole sodium sesquihydrate. The blue crosses represent the observed data points, and the green line is the
calculated pattern. The cyan curve is the normalized error plot. The vertical scale has been multiplied by a factor of 20× for 2θ > 9.5°.
Figure 3. Comparison of the synchrotron powder pattern (blue XRD pattern) of pantoprazole sodium sesquihydrate to PDF entry 00-058-1368 (blue stick
pattern) (Badwan et al., 2002) and a low-precision pattern of pantoprazole sodium sesquihydrate (green XRD pattern) (Reddy et al., 2005).
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Rietveld refinement was carried out using GSAS-II (Toby
and Von Dreele, 2013). Only the 1.0–22.0° portion of the
pattern was included in the refinement (dmin = 1.084 Å). All
non-H-bond distances and angles in the anions were subjected
to restraints based on a Mercury/Mogul Geometry Check
(Bruno et al., 2004; Sykes et al., 2011) of the molecule. The
Na–ligand bonds were not restrained. The pyridine and benzi-
midazole ring systems were restrained to be planar. The results
were exported to a .csv file. The Mogul average and standard
deviation for each quantity were used as the restraint parame-
ters and were incorporated using the new feature Restraints/
Edit Restraints/Add MOGUL Restraints, which read the
bond distance and angle restraints from the csv file. The
restraints contributed 7.4% to the final χ2. The hydrogen
atoms were included in calculated positions, which were
recalculated during the refinement using Materials Studio
(Dassault, 2018). The positions of the active hydrogen
atoms were deduced by the analysis of potential hydrogen
bonding patterns. The Uiso of the non-H atoms of the two
anions were constrained to be the same. The Uiso of the
non-H atoms were grouped by chemical similarity. A common
Uiso was refined for the atoms of the pyridine rings, the
methoxy groups attached to the pyridine rings, the methylene
C and sulfoxide O in the center of the anion, the S, the atoms
of the benzimidazole ring system, the difluoromethoxy group,
the Na, and the water molecule O atoms. The Uiso for each
hydrogen atom was constrained to be 1.3× that of the heavy
atom to which it is attached. The background was modeled
Figure 4. (a) Comparison of the Rietveld-refined (red) and VASP-optimized (blue) structures of anion 1 of pantoprazole sodium sesquihydrate. The rms
Cartesian displacement is 0.322 Å. (b) Comparison of the Rietveld-refined (red) and VASP-optimized (blue) structures of anion 2 of pantoprazole sodium
sesquihydrate. The rms Cartesian displacement is 0.416 Å.
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using a three-term shifted Chebyshev polynomial and a six-
term diffuse scattering function to model the scattering from
the Kapton capillary and any amorphous component.
The final refinement of 191 variables using 21 003 observa-
tions and 138 restraints yielded the residuals Rwp= 0.1165 and
GOF= 2.62. The largest peak (0.41 Å from S12) and the hole
(1.29 Å from S38) in the difference Fourier map were 0.55 and
−0.40(10) eÅ−3. The Rietveld plot is included in Figure 2.
The largest errors in the fit are in the intensities of some of the
peaks and may represent an incomplete structural model.
A density functional geometry optimization was carried
out using CRYSTAL14 (Dovesi et al., 2014). The basis sets
for the H, C, N, and O atoms were those of Gatti et al.
(1994), and the basis sets for S and Na were those of
Peintinger et al. (2013). The calculation was run on eight
2.1 GHz Xeon cores (each with 6 Gb RAM) of a 304-core
Dell Linux cluster at IIT, using eight k-points and the
B3LYP functional, and took ∼30 days.
III. RESULTS AND DISCUSSION
The powder pattern of the pantoprazole sodium sesquihy-
drate studied here matches that of U.S. Patent 6,933,389 B2
(PDF entry 00-058-1451; Reddy et al., 2005) well enough
to conclude that the two materials are the same, and that our
sample is representative of Form I (Figure 3).
The refined atom coordinates of pantoprazole sodium ses-
quihydrate and the coordinates from the density function the-
ory (DFT) optimization are reported in the Crystallographic
Information Frameworks (CIFs). The root-mean-square
Cartesian displacement of the non-hydrogen atoms in the
Rietveld-refined and DFT-optimized structures of anion 1 is
0.322 Å [Figure 4(a)], and the rms displacement for anion 2
is 0.416 Å [Figure 4(b)]. The agreement between the refined
and optimized structures is at the upper end of the range for
correct structures (van de Streek and Neumann, 2014).
Refinement of this very large structure with limited powder
data means that this should perhaps be considered as a pro-
posed structure. This discussion concentrates on the
CRYSTAL-optimized structure. The asymmetric unit (with
atom numbering) is illustrated in Figure 5, and the crystal
structure is presented in Figure 6.
The crystal structure is characterized by layers parallel to
the bc-plane [Figure 6(a)]. One layer contains the Na coordi-
nation spheres. Na53 is five-coordinate (trigonal bipyramidal),
and Na54 is six-coordinate (octahedral). Na53 is coordinated
to two water molecules O55 and O57, the sulfoxide O13, and
two nitrogens of the imidazole ring (N41 and N43). Na54 is
coordinated to the water molecule O56, the sulfoxide oxygens
O13 and O39, the methoxy oxygen O9, and N17 and N43,
which are the part of the imidazole rings. The NaO3N2
and NaO4N2 share the O13–N43 edge to form pairs
[Figure 6(b)]. The bond valence sums of Na53 and Na54 are
1.17 and 1.15, respectively. The Mulliken overlap populations
(∼0.01 e) indicate that Na–O/N bonds are mostly ionic, with
only slight covalent character. Another layer is formed by con-
tacts between the difluoromethyl and methoxy groups. The
large displacement coefficient of the difluoromethyl groups
probably means that they are disordered. Since an ordered
model is necessary for the DFT calculation, we chose to let
Figure 5. Asymmetric unit of pantoprazole sodium sesquihydrate, with the atom numbering. The atoms are represented by 50% probability spheroids.
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the Uiso become large. We know from the molecular structure
that the pantoprazole anions are ionized at the imidazole rings.
Anion 1 is coordinated to Na54 only through N17 (and not
N15). Anion 2 is coordinated to Na through both N41
(Na53) and N43 (Na53 and Na54). The atomic charges of
N15, N17, N41, and N43 are −0.520, −0.581, −0.584, and
−0.618 e, respectively. The charges of Na53 and Na54 are
0.890 and 0.885 e. The least-negative N15 is not coordinated
to Na, confirming that electrostatic contributions are important
in the Na–N bonds.
Figure 6. (a) Crystal structure of pantoprazole sodium sesquihydrate viewed down the c-axis. (b) Crystal structure of pantoprazole sodium sesquihydrate viewed
nearly down the a-axis.
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Most of the bond distances, bond angles, and torsion
angles in the anions fall within the normal ranges indicated
by a Mercury Mogul Geometry check (Macrae et al., 2008).
The S12–C14 and S38–C40 bond distances of 1.818
and 1.822 Å are flagged as unusual (average = 1.780(10) Å;
Z-scores = 3.87 and 4.22), perhaps because of the small uncer-
tainty on the average. The S38–C40–N43 angle of 118.3°
(average = 122.0°; Z-score = 4.54) is flagged as unusual. The
N43–C40–S38–O39 torsion of 1.8° lies on the tail of a
broad distribution, peaking mainly from 0 to 50°. The N15–
C14–S12–O13 torsion of 13.0° lies in a broad distribution,
with a peak ∼135°. The N17–C14–S12–O13 torsion of
−173.8° lies in a broad distribution with a peak ∼45°. All
of the unusual geometrical features involve the S atoms, sug-
gesting that the DFT calculation is weakest for these atoms.
The two independent anions have similar but different
conformations (Figure 7). Quantum chemical geometry opti-
mization of the pantoprazole anion (DFT/B3LYP/6-31G*/
water) using Spartan’18 (Wavefunction, 2018) indicated
that the conformation of anion 2 is 64.7 kcal mol−1 lower
in energy than anion 1. The molecular mechanics conforma-
tional analysis indicated that the minimum-energy molecular
conformation is more compact than the observed ones, with
the pyridine ring rotated toward the benzimidazole ring.
Intermolecular interactions, thus, are important to determine
the observed conformations.
The analysis of the contributions to the total crystal
energy using the Forcite module of Materials Studio
(Dassault, 2018) suggests that angle and torsion distortion
terms are dominant in the intramolecular deformation energy,
as might be expected for anions containing a fused ring system
and which are coordinated to cations. The intermolecular
energy is dominated by electrostatic attractions, which in
this force field-based analysis include cation coordination
and hydrogen bonds. The hydrogen bonds are better analyzed
using the results of the DFT calculation.
Beside coordinating to the Na cations, the water mole-
cules act as donors in hydrogen bonds (Table I). Both
O–H⋯O and O–H⋯N hydrogen bonds are present, and the
energies of the O–H⋯O bonds were calculated using the
Figure 7. Comparison of the two independent anions in pantoprazole sodium sesquihydrate. Anion 1 is in green, and anion 2 is in orange.
TABLE I. Hydrogen bonds (CRYSTAL14) in pantoprazole sodium sesquihydrate.
H-bond D–H (Å) H⋯A (Å) D⋯A (Å) D–H⋯A (°) Overlap (e) E (kcal mol−1)
O57–H91⋯N32 0.981 1.864 2.824 165.3 0.060 a
O57–H90⋯O39 0.980 1.795 2.733 159.2 0.051 12.3
O56–H89⋯N6 0.995 1.803 3.257 149.1 0.070 a
O56–H88⋯O13 0.979 2.147 2.868 129.2 0.025 8.6
O56–H88⋯N15 0.979 2.300 3.160 146.0 0.026 a
O55–H86⋯O56 0.991 1.738 2.724 172.9 0.074 14.9
C46–H83⋯N15 1.088 2.424 3.479 162.9 0.025 a
C37–H80⋯O55 1.090 2.474 3.515 159.3 0.029 a
C20–H69⋯O39 1.082 2.390 3.091 121.1 0.018 a
C11–H67⋯O55 1.089 2.510 3.528 156.7 0.030 a
aCorrelation between overlap population and hydrogen bond energy not yet available for C–H⋯O, O–H⋯N, and C–H⋯N hydrogen bonds.
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correlation of Rammohan and Kaduk (2018). Both O57 and
O56 act as donors to pyridine nitrogens and sulfoxide oxy-
gens. H88, which is on O55, participates in bifurcated hydro-
gen bonds to O13 and N15. H87 does not act as a donor, but
O55 acts as an acceptor in two C–H⋯O hydrogen bonds.
The volume enclosed by the Hirshfeld surface (Figure 8;
Hirshfeld, 1977; Turner et al., 2017) is 967.66 Å3, 98.59% of
1/8 the unit cell volume. The packing density is thus normal.
All of the significant close contacts (red in Figure 8) involve
the hydrogen bonds. The volume/non-hydrogen atom is
18.5 Å3.
The Bravais–Friedel–Donnay–Harker (Bravais, 1866;
Friedel, 1907; Donnay and Harker, 1937) morphology sug-
gests that we might expect platy morphology for pantoprazole
sodium sesquihydrate, with {200} as the principal faces. A
second-order spherical harmonics model was included in the
refinement. The texture index was 1.002, indicating that the
preferred orientation was not significant in the rotated capil-
lary specimen. The powder pattern of pantoprazole sodium
sesquihydrate from a Le Bail extraction of this synchrotron
data set is included in the Powder Diffraction File™ as entry
00–65-1424.
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